Powered by

Powered by Portfolio Grader

Crispr Therapeutics Ag (CRSP)

36.26 0.17 (0.47%) 19:18 EDT
CRSP Stock Quote Delayed 15 Minutes

  • CRSP Stock Chart

  • Historical CRSP Prices

  
Dividend & Yield:       N/A (N/A)
P/E:       -
Market Cap:       1.70B
EPS:       -
Volume:       530,400
Day's Range:       35.15 - 36.76
52wk Range:       22.22 - 73.90
Quotes delayed at least 20 mins.
Historical Data for CRSP
Month:  Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
Year:  2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
Range:  1 Month 3 Month 1 Year
Date Open High Low Volume Close Change %
04/18/19 36.73 36.76 35.15 530,400 36.26 -0.17   -0.47%
04/17/19 39.11 39.75 35.15 1,585,817 36.43 -2.65   -6.78%
04/16/19 38.75 40.94 38.43 1,161,295 39.08 1.93   5.20%
04/15/19 38.00 38.24 36.64 341,107 37.15 -0.76   -2.00%
04/12/19 37.99 38.30 37.39 335,600 37.91 0.40   1.07%
04/11/19 38.83 39.29 36.75 547,480 37.51 -1.31   -3.37%
04/10/19 37.86 38.84 37.68 357,302 38.82 1.14   3.03%
04/09/19 38.66 38.87 37.51 408,282 37.68 -0.99   -2.56%
04/08/19 38.42 39.39 37.37 456,860 38.67 0.25   0.65%
04/05/19 38.37 38.51 37.91 359,000 38.42 0.27   0.71%
04/04/19 38.16 38.49 37.21 413,159 38.15 -0.09   -0.24%
04/03/19 38.22 38.35 37.52 458,251 38.24 0.34   0.90%
04/02/19 35.43 38.34 35.43 811,973 37.90 2.45   6.91%
04/01/19 36.25 36.35 34.91 431,541 35.45 -0.27   -0.76%
03/29/19 35.45 35.98 34.96 444,800 35.72 0.79   2.26%
03/28/19 34.35 35.17 34.10 293,177 34.93 0.72   2.10%
03/27/19 34.85 35.13 33.61 396,380 34.21 -0.62   -1.78%
03/26/19 34.73 35.20 34.31 489,520 34.83 0.64   1.87%
03/25/19 35.40 35.91 33.55 761,221 34.19 -1.40   -3.93%
03/22/19 37.57 38.00 35.18 709,000 35.59 -2.27   -6.00%
03/21/19 36.64 38.40 36.64 531,241 37.86 0.76   2.05%
03/20/19 37.42 37.49 35.92 495,347 37.10 -0.14   -0.38%
03/19/19 38.09 38.30 36.72 545,900 37.24 -0.64   -1.69%
03/18/19 38.89 39.60 37.41 700,715 37.88 -0.76   -1.97%
03/15/19 38.62 39.57 38.51 637,000 38.64 0.09   0.23%
03/14/19 39.37 39.76 38.04 406,488 38.55 -0.88   -2.23%
03/13/19 39.71 39.85 38.41 683,015 39.43 0.02   0.05%
03/12/19 39.59 39.89 39.08 460,857 39.41 0.37   0.95%
03/11/19 37.69 39.11 37.27 509,783 39.04 1.34   3.55%
03/08/19 37.61 38.64 36.68 595,700 37.70 -1.00   -2.58%
03/07/19 38.32 39.47 37.02 554,890 38.70 0.31   0.81%
03/06/19 40.85 41.12 37.74 974,286 38.39 -2.48   -6.07%
03/05/19 39.92 41.90 39.25 1,363,457 40.87 0.95   2.38%
03/04/19 42.03 42.03 38.28 2,229,804 39.92 -0.05   -0.13%
03/01/19 35.83 40.05 35.34 1,877,100 39.97 4.58   12.94%
02/28/19 36.85 37.19 34.83 665,643 35.39 -1.34   -3.65%
02/27/19 36.25 37.63 35.60 891,891 36.73 0.53   1.46%
02/26/19 39.53 39.75 36.07 1,376,652 36.20 -3.45   -8.70%
02/25/19 34.95 40.05 34.00 4,109,194 39.65 7.98   25.20%
02/22/19 31.15 31.96 30.83 628,000 31.67 0.49   1.57%
02/21/19 31.88 31.97 30.75 497,951 31.18 -0.81   -2.53%
02/20/19 32.61 32.85 31.50 408,700 31.99 -0.42   -1.30%
02/19/19 31.37 32.91 31.37 510,368 32.41 0.89   2.82%
02/15/19 31.10 31.78 30.81 416,500 31.52 0.59   1.91%
02/14/19 30.97 31.31 30.53 277,184 30.93 -0.18   -0.58%
02/13/19 31.79 32.15 30.89 361,132 31.11 -0.53   -1.68%
02/12/19 31.20 31.90 31.07 427,804 31.64 0.51   1.64%
02/11/19 30.62 31.94 30.04 522,619 31.13 0.74   2.44%
02/08/19 30.26 31.06 29.92 704,400 30.39 0.61   2.05%
02/07/19 32.38 32.47 29.34 928,902 29.78 -2.85   -8.73%
02/06/19 32.31 32.68 31.65 339,250 32.63 0.19   0.59%
02/05/19 32.69 33.73 32.07 384,868 32.44 -0.14   -0.43%
Download Data To Spreadsheet
Crispr Therapeutics Ag (CRSP) Stock Rating from Louis Navellier

Navellier Ratings

Powered by Portfolio Grader

Crispr Therapeutics Ag Stock Analysis

Rating: Sell

Total Grade: D

Analysis Breakdown

CRSP Stock Grade: D
Fundamental Grade: F
Quantitative Grade: D
CRSP Earnings
Earnings Growth: F
Earnings Momentum: D
Earnings Surprises: D
Analyst Earnings Revisions: D
CRSP Financial Information
Sales Growth: F
Operating Margin Growth: F
Cash Flow: D
Return on Equity: F

Crispr Therapeutics Ag Stock: Weekly View

This Week: D
Last Week: D
Two Weeks Ago: D
Get Full Report